Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
DENTSPLY SIRONA ( (XRAY) ) just unveiled an update.
On July 21, 2025, Dentsply Sirona announced the appointment of Daniel T. Scavilla as President and Chief Executive Officer, effective August 1, 2025, succeeding Simon D. Campion. Mr. Scavilla brings extensive experience from his previous roles at Globus Medical and Johnson & Johnson, where he held various leadership positions. The company also released select preliminary financial results for the second quarter of 2025, expecting net sales of approximately $935 million and adjusted earnings per share between $0.50 and $0.52. This leadership transition and financial update are part of Dentsply Sirona’s ongoing efforts to enhance value for shareholders and position itself as a leader in the dental market.
The most recent analyst rating on (XRAY) stock is a Hold with a $28.00 price target. To see the full list of analyst forecasts on DENTSPLY SIRONA stock, see the XRAY Stock Forecast page.
Spark’s Take on XRAY Stock
According to Spark, TipRanks’ AI Analyst, XRAY is a Neutral.
DENTSPLY SIRONA’s overall score reflects significant financial challenges with declining revenues and profitability, which heavily impact its valuation. However, technical analysis shows neutral momentum, and recent corporate events suggest improved leadership and financial flexibility. The earnings call highlights operational efficiencies and innovation, providing a balanced outlook despite existing challenges.
To see Spark’s full report on XRAY stock, click here.
More about DENTSPLY SIRONA
Dentsply Sirona is the world’s largest diversified manufacturer of professional dental products and technologies, with a history of over a century in innovation and service to the dental industry. The company develops, manufactures, and markets a comprehensive range of dental and oral health products, as well as other consumable medical devices, under a portfolio of world-class brands. Its headquarters is located in Charlotte, North Carolina, and its shares are listed on Nasdaq under the symbol XRAY.
Average Trading Volume: 2,592,490
Technical Sentiment Signal: Sell
Current Market Cap: $3.12B
Find detailed analytics on XRAY stock on TipRanks’ Stock Analysis page.